Funded Projects › HORIZON
INTERCEPTOR · INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response
Emerging infectious diseases (EID) do not respect borders. They rank as global catastrophic risks for humanity, along with climate change and biodiversity loss. The COVID-19 pandemic showed how coordination of global research, through cooperation, and sharing of data and expertise, are crucial for efficient and effective preparedness to EIDs, and vital for a rapid response. Nevertheless, there are still major challenges limiting global cooperation among high containment laboratories (HCLs). HCLs are critical infrastructures for the development of medical countermeasures (e.g., vaccines and therapeutics) against high consequence pathogens. In order to fulfil its role, and given the global threat of EIDs, the European Research Infrastructure on Highly pathogenic Agents (ERINHA), together with its partners, proposes to establish and reinforce interactions with HCL research infrastructures (RI) worldwide, to strengthen pandemic preparedness and response capacities. INTERCEPTOR (INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response), a consortium with key HCLs from Europe and across the world, will focus on access provision to HCLs, enhancement of the human capital of HCL, including in biorisk management, critical resources sharing, harmonisation and interoperability. The proposed actions will help ensure broader access to state-of-the-art HC facilities, while respecting the necessary biosecurity and biosafety constraints, and promote the establishment of a sustainable global network of HC RIs. By expanding access to HC RIs, strengthening the human capital base, promoting sharing of knowledge, skills and experience, and providing opportunities for common training programmes and staff exchanges, INTERCEPTOR will reinforce the next generation of HCL researchers and facility managers, and extend the opportunities for access to HCLs, required to push the boundaries of science and innovation in the field of EIDs.
Consortium · 24 organisations
EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS
BE · €308,313
PHILIPPS UNIVERSITAET MARBURG
DE · €83,035
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €107,875
A*STAR Infectious Diseases Labs
SG
MEDIZINISCHE UNIVERSITAT GRAZ
AT · €192,241
ROBERT KOCH-INSTITUT
DE
NATIONAL HEALTH LABORATORY SERVICES
ZA · €110,482
INSTITUTO DE SALUD CARLOS III
ES · €58,913
The University of Texas Medical Branch at Galveston
US
INSTITUT PASTEUR KOREA
KR
NEMZETI NEPEGESZSEGUGYI ES GYOGYSZERESZETI KOZPONT
HU · €87,025
Department of Health
UK · €75,983
FUNDACAO OSWALDO CRUZ
BR
CENTRO NACIONAL DE PESQUISA EM ENERGIA E MATERIAS ASSOCIACAO PRIVADA
BR
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
PT · €78,433
NATIONAL UNIVERSITY OF SINGAPORE PUBLIC COMPANY LIMITED BY GUARANTEE
SG
EIDGENOSSISCHES DEPARTEMENT FUR VERTEIDIGUNG, BEVOLKERUNGSSCHUTZ UND SPORT
CH · €125,141
COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
AU · €118,262
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO
IT · €38,875
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
NL
UNIVERSITY OF MALAYA
MY
UNIVERSITY OF SASKATCHEWAN
CA
FOLKHALSOMYNDIGHETEN
SE · €113,500
PECSI TUDOMANYEGYETEM - UNIVERSITY OF PECS
HU
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.